Project Grant RF1NS134833
Award Date
9/18/24
Completion Date
8/31/27
Dollars Obligated
$2.2M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
This $7,704,350 project grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the mechanisms underlying heterogeneity in cognitive outcomes among individuals with Lewy body disorders (LBD), which include Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease with Lewy bodies. The grant will fund four synergistic research projects focused on: 1) the interplay of alpha-synuclein with amyloid and tau pathologies, 2) characterizing human...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $655,638 to the University of Denver to develop and test synthetic protein mimetics as potential therapeutics for Lewy body dementia (LBD). The key products and services being delivered under this 2.5-year award include: Optimization and testing of the pharmaceutical properties of oligopyridylamide (OP) synthetic protein mimetics to inhibit alpha-synuclein aggregation and Lewy...
The National Institute on Aging (NIA) awarded a $400,707 Project Grant (CFDA 93.866 - Aging Research) to the University of Florida to map brain lipid architecture in aging, Lewy body dementia (LBD), and T-cell therapy. The 2-year grant, running from September 1, 2024 to August 31, 2026, will utilize novel imaging mass spectrometry to generate a spatial atlas of the lipidome and identify lipid markers of disease progression in LBD. The research aims to assess lipid alterations resulting from an...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding research on the role of microglia/macrophages in Lewy body disorders. The total award amount is $231,826.00, with a project period from September 17, 2024 to August 31, 2026. The key objectives of the research are to: 1) identify the neural cell type most likely...
This $2,768,769 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate the influence of the GBA1 gene on the regulation, trafficking, and maturation of key lysosomal proteins involved in the metabolism of alpha-synuclein. The research will use wildtype and isogenic iPSC-derived neurons to examine how GBA1 mutations affect alpha-synuclein degradation, neuronal release, and the accumulation of alpha-synuclein species found in Lewy...
The National Institute on Aging (NIA) awarded a $1,510,600 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of Wisconsin-Madison. The grant supports a 5-year research project to map differences in synaptic density using PET and MRI imaging across the spectrum of Lewy body dementia, from healthy aging to prodromal and manifest stages. The project aims to (1) compare synaptic density between control, rapid eye movement sleep behavior disorder,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $350,036 to the University of Alabama at Birmingham to conduct research aimed at understanding the cellular and molecular changes in a specific subpopulation of neurons that are associated with the development of levodopa-induced dyskinesia (LID), a debilitating side effect of...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and test an advanced magnetic resonance imaging (MRI) technique called velocity-selective arterial spin labeling (VSASL) to serve as a reliable biomarker for detecting early cognitive impairment and disease progression in patients with Lewy body dementia (LBD). The $420,683 award, with a period of performance from September 2024 to July 2029, will fund technical refinements to the...
This $2,069,215 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research by Case Western Reserve University to investigate the role of the beta-arrestin2-LMBRD2 pathway in the transmission and toxicity of pathological alpha-synuclein, which is a defining hallmark of Lewy body diseases such as Parkinson's disease and dementia with Lewy bodies. The research will utilize cellular and animal models to study the mechanisms by which beta-arrestin2...
This $1,707,089 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research by Northwestern University to investigate synergistic approaches for enhancing endoplasmic reticulum (ER) proteostasis, protein trafficking, and lysosomal activity as potential treatments for dementia with Lewy bodies and Parkinson's disease-dementia. The research will use patient-derived induced pluripotent stem cell neuron models and mouse models to test the effects of...